Subjects to be considered in partial replicate BE study [RSABE / ABEL]

posted by Dr_Dan  – Germany, 2015-01-08 09:59 (3682 d 03:51 ago) – Posting: # 14245
Views: 29,552

Dear Detlew
I agree that the study protocol text is insufficiently verbalized. However, if a subject completes two periods, he/she can be included either in the assessment of bioequivalence (in case of one period with test and the other with reference) or in the assessment of within-subject variability of the reference product (in case both periods with reference), right?
Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,376 posts in 4,912 threads, 1,666 registered users;
179 visitors (0 registered, 179 guests [including 10 identified bots]).
Forum time: 13:50 CET (Europe/Vienna)

Operational hectic replaces
intellectual calms.    Alexander Huiskes

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5